Please use this identifier to cite or link to this item:
Title: CD26/DPPIV and response to hepatitis B vaccination
Authors: Dourado, Marília 
Alves, Vera 
Mesquita, Luis 
Ramos, Isabel 
Mota-Pinto, Anabela 
Santos-Rosa, Manuel 
Keywords: CD26/DPPIV; Hepatite B; Vacina
Issue Date: 2006
Serial title, monograph or event: Pathophysiology
Volume: 11
Issue: 3
Abstract: The prevention of hepatitis B is important, since it is responsible for significant morbidity and mortality around the world. Unfortunately, hepatitis B vaccine does not always induce protective immunity. The lack of immune response to vaccine (non-responders) can depend on individual characteristics. The objective of this study was to correlate the CD26/DPPIV cellular expression and DPPIV serum activity with HBV vaccine response and its possible role as an indicator of immune competence acquisition.We also determined the cellular expression of CD3, CD19, CD56 and CD25 in peripheral blood T lymphocytes. Blood samples were obtained from 28 healthy human volunteers who were enrolled with a vaccination program. There were “responders” (RM = 13) and “non-responders” (NRM = 15), after vaccination. The lymphocyte populations were identified by flow cytometry. DPPIV serum activity was measured fluorimetrically. CD26 expression in responders (55.9 ± 7.7%) versus in non-responders (51.9 ± 7.0%) did not show a significant difference. The DPPIV serum activity in responders compared to in non-responder subgroup (59.9 ± 8.4/50.3 ± 10.6 U/L) showed, however, a significant difference (P < 0.05). The expression of CD3, CD19 and CD56 on peripheral lymphocytes was similar between responders and non-responders. The expression of CD3CD26 (52.2 ± 8.6%) and CD3CD25 (10.9 ± 3.8%) in responders versus the expression of CD3CD26 (48.0 ± 5.7%) and CD3CD25 (8 ± 4.6%) in non-responders did not show statistically significant difference. CD25 referred as a marker of T lymphocyte activation was increased in responders (15.8 ± 4.5%) versus in non-responders (10.1 ± 4.8%), showing a significant difference (P = 0.003). It was, however, impossible to demonstrate an increase in CD3CD25 and CD3CD26 in the responder subgroup. This suggests that different lymphocyte subsets other than T cells are implicated in the response to hepatitis B vaccination.
DOI: 10.1016/j.pathophys.2004.06.002
Rights: openAccess
Appears in Collections:FMUC Medicina - Artigos em Revistas Internacionais

Files in This Item:
File Description SizeFormat
CD26:DPPIV and response to hepatitis B vaccination(Pathophysiology2004).pdf148.65 kBAdobe PDFView/Open
Show full item record


checked on Nov 8, 2019

Page view(s)

checked on Dec 10, 2019

Download(s) 50

checked on Dec 10, 2019

Google ScholarTM




Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.